TAK-438
TAK-438/CPH-001
Phase 1 small_molecule completed
Quick answer
TAK-438 for Ascending Single Dose Study is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Ascending Single Dose Study
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed